Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that it has begun enrollment in the SHIELD ...
(Reuters) - Researchers have found a higher rate of dangerous blood clots in patients who received Thoratec Corp's HeartMate II heart pump than had been seen in clinical trials or prior experience, ...
A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA's most serious recall, the agency announced Monday. The recall comes years after surgeons say they ...
The findings suggest clinicians don’t need to be as aggressive in lowering BP in this population, at least early after ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Pharmacotherapy for advanced heart failure patients with a HeartMate 3 left ventricular assist device (LVAD) is being simplified following US Food and Drug Administration approval of a labeling change ...
ORLANDO, Florida (Reuters) - Advanced heart failure patients who received Thoratec Corp's new pump awaiting U.S. approval as an alternative to heart transplants lived longer and fared far better than ...
A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA’s most serious recall, the agency announced Monday. Related Article: Patients Facing Death Are Opting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results